SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-035558
Filing Date
2023-07-28
Accepted
2023-07-28 16:48:38
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20230630.htm   iXBRL 10-Q 1991950
2 EX-10.1 cycn-ex10_1.htm EX-10.1 100565
3 EX-31.1 cycn-ex31_1.htm EX-31.1 14936
4 EX-31.2 cycn-ex31_2.htm EX-31.2 14944
5 EX-32.1 cycn-ex32_1.htm EX-32.1 8556
6 EX-32.2 cycn-ex32_2.htm EX-32.2 8566
  Complete submission text file 0000950170-23-035558.txt   7122712

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20230630_cal.xml EX-101.CAL 30974
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20230630_pre.xml EX-101.PRE 301645
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20230630_def.xml EX-101.DEF 200369
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20230630_lab.xml EX-101.LAB 422087
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20230630.xsd EX-101.SCH 51126
56 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20230630_htm.xml XML 1173884
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 231123758
SIC: 2834 Pharmaceutical Preparations